Literature DB >> 30414460

Outcomes following implantable cardioverter-defibrillator generator replacement in patients with recovered left ventricular systolic function: The National Cardiovascular Data Registry.

Isac C Thomas1, Yongfei Wang2, Vincent Y See3, Karl E Minges2, Jeptha P Curtis2, Jonathan C Hsu4.   

Abstract

BACKGROUND: Some patients with heart failure (HF) experience recovery of left ventricular (LV) systolic function by the end of their implantable cardioverter-defibrillator (ICD) generator battery life. Outcomes following generator replacement in this setting are poorly understood.
OBJECTIVE: We sought to describe outcomes following ICD generator replacement associated with recovery of LV systolic function.
METHODS: We evaluated 26,197 Medicare beneficiaries enrolled in the American College of Cardiology's National Cardiovascular Data Registry ICD Registry who underwent primary prevention ICD generator replacement between 2006 and 2009, stratified by LV ejection fraction (LVEF): reduced (LVEF ≤35%), partially recovered (LVEF >35% and ≤50%), and recovered (LVEF >50%).
RESULTS: At the time of generator replacement, 1915 (7.3%) patients had recovered LVEF and 4576 (17.5%) had partially recovered LVEF. Periprocedural events were rare (<1%) in all patients. In patients with reduced LVEF, the incidence of HF readmission and mortality at 3 years was 27.5% and 32.7%, respectively. In comparison, the rates of HF readmission and mortality were lower for patients with partially recovered LVEF (readmission: 15.9%; hazard ratio [HR] 0.66; 95% confidence interval [CI] 0.61-0.72; mortality: 23.0%; HR 0.82; 95% CI 0.76-0.87) and those with recovered LVEF (readmission: 12.2%; HR 0.55; 95% CI 0.48-0.63; mortality: 18.2%; HR 0.72; 95% CI 0.64-0.80).
CONCLUSION: Patients with partially recovered and recovered LVEF have lower risks of mid-term adverse outcomes than do those with reduced LVEF following ICD generator replacement. Approximately 3 in 4 patients continue to have reduced LVEF at the time of generator replacement and are at high risk of HF readmission and mortality. These data highlight the prognostic associations of LVEF in patients undergoing generator replacement as well as the clinical encounter for generator replacement as an opportunity to identify those at increased risk of adverse outcomes.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse events; Generator replacement; Heart failure; Implantable-cardioverter defibrillator; Mortality; Outcomes; Readmission; Registry

Year:  2018        PMID: 30414460     DOI: 10.1016/j.hrthm.2018.11.005

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  3 in total

1.  Implantable loop recorder as a strategy following cardiovascular implantable electronic device extraction without reimplantation.

Authors:  Antoinette Birs; Douglas Darden; Michael Eskander; Travis Pollema; Gordon Ho; Ulrika Birgersdotter-Green
Journal:  Pacing Clin Electrophysiol       Date:  2022-06-01       Impact factor: 1.912

2.  Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes.

Authors:  Kenneth C Bilchick; Yongfei Wang; Jeptha P Curtis; Ramin Shadman; Todd F Dardas; Inder Anand; Lars H Lund; Ulf Dahlström; Ulrik Sartipy; Wayne C Levy
Journal:  J Am Heart Assoc       Date:  2022-06-29       Impact factor: 6.106

Review 3.  Heart failure with recovered ejection fraction and the utility of defibrillator therapy: a review.

Authors:  Jasneet K Devgun; Samuel Kennedy; Jeremy Slivnick; Zachary Garrett; Katherine Dodd; Mohamed H Derbala; Cristina Ortiz; Sakima A Smith
Journal:  ESC Heart Fail       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.